Skip to main content
Clinical Trials/NCT04421196
NCT04421196
Withdrawn
Not Applicable

Opioid-free Total Hip Arthroplasty: A Randomized Controlled Trial

Johns Hopkins University0 sitesSeptember 15, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hip Osteoarthritis
Sponsor
Johns Hopkins University
Primary Endpoint
Change in post-operative pain assessed by the Visual analog scale (VAS) pain scores
Status
Withdrawn
Last Updated
3 years ago

Overview

Brief Summary

The primary objective of investigators' proposed study is to demonstrate that the following two cohorts undergoing total hip arthroplasty will have equivalent visual analog scale (VAS) scores up to 3 months post-operatively: one that is administered a modified multimodal analgesic pathway without opioids and the other administered the current standard multimodal analgesic pathway used at Johns Hopkins Bayview Hospital (which includes opioids). The secondary objective is to demonstrate that these cohorts will also have equivalent functional outcomes as determined by both objective measures (such as hip range of motion) and patient-reported outcome measures, such as the Hip Disability and Osteoarthritis Outcome Score (HOOS) and the University of California at Los Angeles (UCLA) activity score.

Registry
clinicaltrials.gov
Start Date
September 15, 2022
End Date
December 1, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients of all ages with end-stage primary hip osteoarthritis.

Exclusion Criteria

  • Patients with creatinine clearance between 30 and 60 mL/min
  • Use of any opioid analgesics in the 6 months preceding surgery
  • Revision total hip arthroplasty
  • Patients with liver insufficiency
  • Patients on chronic anticoagulation
  • Workers compensation patients
  • Patients who cannot receive Acetaminophen, Ketorolac, Celecoxib, or Gabapentin for any reason (e.g. allergies)

Outcomes

Primary Outcomes

Change in post-operative pain assessed by the Visual analog scale (VAS) pain scores

Time Frame: From immediate post-operative period to 3 months post-operatively

Post-operative pain scores ranging from 0 to 10; 0 being no pain and 10 being the worst pain ever felt

Secondary Outcomes

  • Change in pain satisfaction as assessed by Hip Disability and Osteoarthritis Outcome Score (HOOS)(From pre-operative clinic visit to immediate post-operative period, then to 3 months post-operatively)
  • Change in Physical Activity level as assessed by the University of California at Los Angeles (UCLA) Scale(From pre-operative clinic visit to immediate post-operative period, and then to 3 months post-operatively)

Similar Trials